Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2012-03-21

Clinical Trial Update: Safety of Amiodarone and Ranolazine Together in Patients With Angina [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the safety of co-administering amiodarone and ranolazine in patients with angina and related cardiovascular conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amiodarone (amiodarone)
  • Ranolazine (ranolazine)

Snippet

Sponsor: Cardiovascular Consultants of Nevada | Conditions: Chronic Stable Angina, Coronary Artery Disease | Phase 4 | Status: UNKNOWN